(Q45882443)

English

Dose effect and efficacy of rFVIIa in the treatment of haemophilia patients with inhibitors: analysis from the Hemophilia and Thrombosis Research Society Registry

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/15810910

Dose effect and efficacy of rFVIIa in the treatment of haemophilia patients with inhibitors: analysis from the Hemophilia and Thrombosis Research Society Registry (English)

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/15810910

0 references

0 references

0 references

0 references

author name string

R Parameswaran

1

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/15810910

A D Shapiro

2

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/15810910

J C Gill

3

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/15810910

C M Kessler

4

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/15810910

HTRS Registry Investigators

5

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/15810910

publication date

1 March 2005

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/15810910

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/15810910

11

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/15810910

2

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/15810910

100-106

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/15810910

Incidence of inhibitors in haemophilia A patients--a review of recent studies of recombinant and plasma-derived factor VIII concentrates

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2005.01075.X

21 January 2018

Incidence of development of factor VIII and factor IX inhibitors in haemophiliacs

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2005.01075.X

21 January 2018

First and second generation recombinant factor VIII concentrates in previously untreated patients: recovery, safety, efficacy, and inhibitor development

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2005.01075.X

21 January 2018

The factor VII-platelet interplay: effectiveness of recombinant factor VIIa in the treatment of bleeding in severe thrombocytopathia.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2005.01075.X

21 January 2018

Recombinant activated factor VII (rFVIIa): characterization, manufacturing, and clinical development

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2005.01075.X

21 January 2018

Platelet activity of high-dose factor VIIa is independent of tissue factor

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2005.01075.X

21 January 2018

Controlling acute bleeding episodes with recombinant factor VIIa in haemophiliacs with inhibitor: continuous infusion and bolus injection

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2005.01075.X

21 January 2018

Rationale for the use of high dose rFVIIa in a high-titre inhibitor patient with haemophilia B during major orthopaedic procedures

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2005.01075.X

21 January 2018

A single high dose of recombinant factor VIIa combining adjuvant therapy for controlling bleeding episodes in haemophiliacs with inhibitors

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2005.01075.X

21 January 2018

A new approach to treatment of bleeding episodes in young hemophilia patients: a single bolus megadose of recombinant activated factor VII (NovoSeven).

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2005.01075.X

21 January 2018

Economic impact of treating inhibitor patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2005.01075.X

21 January 2018

Identifiers

10.1111/J.1365-2516.2005.01075.X

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/15810910

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/15810910

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45882443&oldid=2088341911"